Thank you, Mr. Chairman. My pleasure to introduce Dr. Peggy Plews-Ogan.
Thank you, Mr.
My simple answer is that ALS patients are willing to accept greater risk because we know what is behind door number two.
That is why we need the formality of PPA.
The time is not the right amount of time, and the children are being ignored in this and it shouldn't be that way.
The Promising Pathway Act is a commonsense step to give the FDA the flexibility it needs to serve Americans with these m...
I have been working on this for most of the five-years I have been here in the Senate.
Patients deserve a promising pathway at the FDA.
I have no question that those policies would be much more costly than any reasonable benefits we'd get in any other area...
We've been off the mark for 20 years.
We've given up our energy independence. We've done so many things that tilt the whole analysis.
I think if not, you're at least not going to be in a position where you have credibility to offer other things to do.
All we want as an alternative to certain death is a pathway that allows us access to these therapies at the point where ...
These diseases are relentless. They are widespread and devastating.
